Biological evaluation of the novel 3,3′-((4-nitrophenyl)methylene)bis(4-hydroxy-2<em>H</em>-chromen-2-one) derivative as potential anticancer agents via the selective induction of reactive oxygen species-mediated apoptosis

Publication date: Available online 26 August 2023Source: Cellular SignallingAuthor(s): Sayanta Dutta, Sushweta Mahalanobish, Sukanya Saha, Mullicka Mandal, Sanchari Begam, Pritam Sadhukhan, Sumit Ghosh, Goutam Brahmachari, Parames C. Sil